| BASEC ID | Project title | Type of project | Type of clinical trial | Study phase (clinical trials only) | multi- / monocentric | Category | Principal investigator | Sponsor | Investigational sites | Lead EC | Local EC(s) | Approval date | Minors | Study Ended | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-00212 |
Protocol Amendment A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid® to Discectomy for Primary Lumbar Disc Herniation: Extended Follow-Up of the Barricai More ... |
non clinical, involving persons | monocentric | A | PD Dr. med. Markus Bruder | Intrinsic Therapeutics GmbH |
Kantonsspital, Aarau |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 06.09.2021 | ||||||